Fourth Annual Cardiac Neurodevelopmental Symposium
Children with congenital heart disease have higher rates of neurodevelopmental problems when compared to the general population. There are variations among cardiac centers regarding levels of knowledge about these problems and “best practices” to address them.
The population of children with congenital heart disease who survive to adulthood is growing. Therefore, professionals who work this population need to increase their knowledge about the neurodevelopmental problems these children face, and the best practices to address them in order to maximize QOL across the lifespan.
This symposium will bring together a multidisciplinary group of healthcare professionals to educate them about clinical, quality improvement, and research topics related to neurodevelopmental services for individuals with pediatric and congenital heart disease.
Participants will increase their knowledge about neurodevelopmental services for individuals with congenital heart disease on their symposium evaluation forms that they complete after the conference.
The Medical College of Wisconsin is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
AMA designation of credit:
The Medical College of Wisconsin designates this live activity for a maximum of 12.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Hours of Participation for Allied Health Professionals:
The Medical College of Wisconsin designates this activity for up to 12.5 hours of participation for continuing education for allied health professionals.
Psychology CE Credit:
The Medical College of Wisconsin is approved by the American Psychological Association to sponsorcontinuing education for psychologists. The Medical College of Wisconsin maintains responsibility for this program and its content.
This activity contains content or processes that may be potentially stressful.
- Describe psychological problems found in patients with ventricular assist devices
- Outline sources of funding for cardiac neurodevelopmental outcomes research
- Discuss prenatal factors that impact neurodevelopmental outcomes
The Pfister Hotel
424 E. Wisconsin Ave., Milwaukee 53202
(414) 273-8222 | thepfisterhotel.com
- Alisa Burnham, MD
- Mary R. Gregory, MSN, RN, CNOR
- Andrew Van Bergen, MD
- Ginny O’Harrow
- Lyann Buena-Franco
- Michelle McCardle
- Daniel James Penny, MD, PhD, MHA
- Jeanne Gallen Lewandowski, MD
- George M. Hoffman, MD
- Steven R. Leuthner, MD, MA
- Ismée A. Williams, MD, MS
- Catherine Limperopoulos, PhD
- Samantha Butler, PhD
- Kathleen A. Mussatto, PhD, RN
- Nancy A. Rudd, RN, APNP, MS
- Veronica L. Gunn, MD, MPH
- Andrea Morrison, MD, MS
- Darsell Johns
- Kyle K. Herma
- Aoy Tomita Mitchell, PhD
- Amy L. Delaney, PhD, CCC-SLP,
- Katherine Frontier, MS, CCC-SLP, C/NDT
- Roni Jacobsen, MD
- Michael Danduran, MS
- Nancy S. Ghanayem, MD
- Ronald K. Woods, MD, PhD
- Robert A. Niebler, MD
- Cheryl Brosig Soto, PhD
- Leslie Scott, MS, CCLS
- Julie A. Schmidt, RN, MSN, CPNP
- Jackson Radandt
- Joe Selby, MD
- David Wypij, PhD
- Mary R. Gregory, MSN, RN, CNOR
- Sara K. Pasquali, MD, MHS, C.S.
- Bradley S. Marino, MD, MPP, MSCE
- Gil Wernovsky, MD
In accordance with the ACCME policy on speaker/planner disclosure, all were asked to disclose any relevant financial relationships and no one had any to disclose with the exception of the following:
- George M. Hoffman, MD, Covidien (consultant), Nonin, Inc. (consultant), Children’s Hospital of Boston (visiting professor)
- Ronald K. Woods, MD, PhD, Syncardia (MCW received funds on his behalf)
- Aoy Tomita-Mitchel, PhD, Ariosa Diagnostics (co-founder), TAI Diagnostics (co-founder)
- Sara K. Pasquall, MD, MHS, CS, R01HL122261 (NIH funding), U10HL068270 (NIH funding)
- 12.50 AMA PRA Category 1 Credit(s)™AMA PRA Category 1 Credit(s)™
- 12.50 APAAPA credit.
- 12.50 Hours of ParticipationHours of Participation credit.